HALO — HALOZYME THERAPEUTICS INC

Ownership history in Scientech Research LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.56% (2025 Q2)
Avg. % of fund
0.28%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 11,830 -31,941 -73.0% 0.30% $868K $73.34
2025 Q2 ADDED 43,771 +26,238 +149.6% 0.56% $2.3M $52.02
2025 Q1 ADDED 17,533 +1,432 +8.9% 0.30% $1.1M $63.81
2024 Q4 REDUCED 16,101 -4,050 -20.1% 0.22% $770K $47.81
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HALO price (monthly, adj. close)

Other funds also holding HALO

As of 2025 Q4 — sorted by position size

Koa Wealth Management, LLC 4.3% SNYDER CAPITAL MANAGEMENT L P 3Y 7Y 3.01% Steamboat Capital Partners, LLC 3Y 7Y 2.66% South Street Advisors LLC 3Y 7Y 2.19% BERNZOTT CAPITAL ADVISORS 3Y 7Y 2.17% 2Xideas AG 3Y 1.98% Future Fund LLC 3Y 1.77% MIZUHO MARKETS AMERICAS LLC 3Y 1.65% Verity Asset Management, Inc. 3Y 7Y 1.53% RENAISSANCE GROUP LLC 3Y 7Y 1.3%
← Back to Scientech Research LLC Holdings